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Previewsinterest in learning how different cell types
might be transformed into insulin-pro-
ducing b cells to treat Type 1 diabetes,
which results from autoimmune destruc-
tion of b cells. Although Dhawan et al.
(2011) reveal a potential mechanism to
generate a cells, an analogous strategy
might serve to make new b cells. A recent
report showed that misexpression of
the b cell regulator Pax4 in a cells can
promote their differentiation into b cells
(Collombat et al., 2009). It is therefore
possible that the deletion of Dnmt1 in
a cells might reactivate Pax4, thereby
promoting the transformation of a cells
into b cells. Nonetheless, several funda-
mental questions remain to be solved. For
example, a reprogramming strategy will
require a demonstration that cellular plas-
ticity can also be altered after conditional
deletion of Dnmt1 in adult cells, rather
than in embryonic b cells as reported by
Dhawan et al. (2011). In addition, cells412 Developmental Cell 20, April 19, 2011 ª2that lack a fundamental repressivemecha-
nism may potentially suffer from delete-
rious functional consequences andpheno-
typic instability. Earlier studies, for
example, have shown that DNA methyla-
tion-deficient forebrain neurons exhibit
abnormal gene expression patterns as
well as functional defects (Feng et al.,
2010a). These considerations notwith-
standing, the data from Dhawan et al.
(2011) provide a strong rationale to test
genetic or chemical perturbations of
repressive epigenetic mechanisms in
regenerative medicine.
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The acquisition of a lumen is an essential step in vascularmorphogenesis. In this issue ofDevelopmental Cell,
Xu et al. (2011) show that the small GTPase Rasip is a critical regulator of cytoskeleton dynamics and cell
adhesion, which together drive the emergence of vascular lumens.The vascular system consists of a series
of interconnecting ducts responsible for
the transport of blood and the trafficking
of immune cells. Understanding the
processes that regulate the acquisition,
maintenance, and remodeling of vascular
lumens is thus essential to build concrete
knowledge of vascular development and
function. Unlike lumen formation in
epithelial tubes, the identification of the
molecular players that regulate tube
morphogenesis by endothelial cells has
lagged behind other advances in vascular
biology. In the last decade, genetic
models in zebrafish and mice and inge-
nious in vitro systems that recapitulate
vascular morphogenesis have beendeveloped. The combination of these
systems has paved the way toward initial
characterization of the process by which
vessels gain lumens (Iruela-Arispe and
Davis, 2009). In this issue of Develop-
mental Cell, Xu et al. (2011) report findings
that add to the understanding of lumen
formation.
In vitro studies using three-dimensional
systems contributed significantly to the
body of knowledge regarding vascular
invasion and lumen formation. These
studies brought to light three categories
of molecules: regulators of cytoskeletal
dynamics, polarity proteins, and adhesion
receptors. In particular, it was found that
lumen formation requires integrin sig-naling, activation of Cdc42, Rac1, pak2/
4, Raf kinases, and the Par3/Par6/atypical
PKC complex (Koh et al., 2008, 2009).
More recently, our knowledge of
vascular lumen formation has been ex-
panded through the serendipitous explo-
ration of transgenic mutants. Deletion of
b1 integrin in the endothelial cell compart-
ment resulted in disruption of endothelial
cell polarity and arrest of lumen formation
(Zovein et al., 2010). Because the deletion
occurred by midgestation (E10.5–14.5),
removal of b1 integrin was found to
manifest differently in newer vessels and
in established endothelium. Loss of b1
integrin in the established endothelium
resulted in endothelial stratification and
Figure 1. Acquisition of Endothelial Cell Polarity and Lumen
Formation
Prior to lumen emergence, vessels consist of solid cords of cuboidal endothe-
lial cells that express cell-cell adhesion molecules (ZO1, VE-Cadherin) in the
apical as well as lateral aspects of each cell. The formation of a lumen is trig-
gered by activation of integrins, cytoskeletal dynamics, and rearrangement of
cell-cell adhesion molecules from the apical to the lateral cell membrane, with
concurrent changes in cell shape. Rasip and Arhgap29 participate in the acti-
vation of the cytoskeleton by reducing levels of active Rho and increasing
levels of Cdc42 and Rac. In addition, Rasip alters integrin activation status
and distribution of Par3 to junctional complexes. The effect on Par3 is likely
indirect (dotted arrow).
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Previewscuboidal cell shapes. In
contrast, absence of lumen
was evident in small arteries,
which exhibited mislocaliza-
tion of cell-cell adhesion
molecules and apical endo-
thelial adhesion with oblitera-
tion of lumens. Further mech-
anistic analysis identified the
polarity protein Par3 (pard3)
as a critical downstream re-
gulator. In fact, overexpres-
sion of Par3 was able to
partially rescue the polarity
and lumen defects imparted
by lack of b1 integrin (Zovein
et al., 2010). These results
are consistent with findings
from in vitro models. They
also indicate that changes in
adhesion and lumen defects
are downstream of polarity
cues and that these in turn
are triggered by b1 integrin.
Xu et al. (2011) now
present work that uncovers
additional molecular players
and adds to the under-
standing of the contribution
of the cytoskeleton in lumen
formation. In particular, the
group demonstrated that Ra-
sip1, an endothelial-specific
Ras interacting protein, is
required for organization of
lumens during development.
Genetic inactivation of Ra-
sip1 in mice blocks the emer-
gence of patent lumens in all
blood vessels, leading todevelopmental arrest and lethality by
E10.5. Two binding partners of Rasip1,
nonmuscle myosin heavy chain II
(NMMHCII) and Arhgap29, a RhoA
specificGAP, were identifiedwith obvious
roles in the process. These findings
clearly direct attention to the cytoskeletal
apparatus. Indeed, the lack of Rasip1
upset the balance between Cdc42/Rac1
and RhoA, with mutant cells showing
high levels of actin stress fibers and
decreased acetylated tubulin. Further-
more, Rasip1/Arhgap29 work together to
suppress ROCK, Myosin Light Chain,
and NMMHCII, keeping the actomyosin
complex in a state of adequate contrac-
tion. Depletion of Rasip1 or Arghgpa29
blocked in vitro lumen formation by
altering the cytoskeleton, increasingcontraction and reducing integrin-depen-
dent adhesion. Indeed, the authors
found a significant reduction of b1 integrin
activation (by 70%–80%) but observed no
change in integrin protein levels. These
results suggest that Rasip1 contributes
integrin signaling. In agreement with
previous findings (Zovein et al., 2010),
the authors also observed defective
Par3 trafficking/localization and ectopic
tight junction distribution. An emerging
theme from both studies is that endothe-
lial cell polarity is a critical first step in
lumen formation. In this context, Rasip1
appears to function as a signaling node
essential for coordinating cytoskeleton
dynamics and cell adhesion that lead to
cell polarity and lumen formation
(Figure 1).Developmental Cell 20, April 19While Xu et al. (2011) has
assembled another big piece
of the ‘‘lumen puzzle,’’ mul-
tiple questions still remain.
For example, how does endo-
thelial cell shape and traf-
ficking of membranes change
during lumen formation? How
is the movement of cell-cell
adhesion molecules coordi-
nated and correctly routed to
the lateral aspects of the
membrane in the process of
lumen formation? What are
the layers of regulatory cross
talk between cell-matrix and
cell-cell interactions? Do all
vascular lumens utilize the
same molecular pathways in
their formation? On this last
question, similarly to epithelial
tube morphogenesis, it is
unlikely that all vessels will
form lumens in the same
fashion. Data from in vitro
systems and zebrafish, for
example, indicate that some
capillaries are likely to gain
lumens via fusion of internal
vesicles (Kamei et al., 2006).
In contrast, the aorta, in
a manner seemingly distinct
from other vessels, forms by
the coalescence and subse-
quent fusion of two strings of
vascular cords. The transition
from a cord to a tube is rapid
and dependent on the pro-
cesses described by Xu
et al. (2011), but expansionof the lumen and the accumulation of
fluid in the lumen appears to require the
polarized expression of the sialomucins
CD-34 and podoxalyxin (Strilic et al.,
2009). Coordination of actin contraction
and apical distribution of negatively
charged sialomucins result in the repul-
sion of juxtaposed apical membranes
through the accumulation of interstitial
fluid in the emerging lumen (Strilic et al.,
2009).
As additional studies advance our
understanding of lumen formation, it is
clear that these insights into the nuances
of the regulatory process will continue to
add complexity and clarify organ- or
vessel-specific differences. While these
studies better our understanding of how
vessels acquire lumens, an equally, 2011 ª2011 Elsevier Inc. 413
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Previewspressing question pertains to how the
dynamic control of vessel diameter is
sensed and regulated. Blood vessels
are remarkable structures with the
strength to absorb pressure and the flex-
ibility to adapt to homeostatic needs.
Unraveling the operative molecular web
that coordinates alterations in vessel
diameter will clearly be our next chal-
lenge in understanding vascular
development.414 Developmental Cell 20, April 19, 2011 ª2REFERENCES
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iRhoms are inactive rhomboid-like pseudoproteases that lack essential catalytic residues. Although iRhoms
are highly conserved in metazoan species, little is known about their function. In a recent issue of Cell, Zettl
et al. (2011) show that iRhoms regulate growth factor signaling through endoplasmic reticulum-associated
protein degradation (ERAD).Highly conserved among all sequenced
metazoans, iRhoms are related to rhom-
boid intramembrane serine proteases,
but are not active proteases, as they
lack the essential catalytic residues
required for serine proteases and have
no proteolytic activity. Although their
high degree of conservation between
organisms suggests that these pseudo-
proteases are under evolutionary selec-
tive pressure, their functional significance
is largely unknown. A previous study re-
ported that human iRhom1 interacts with
the human epidermal growth factor
(EGF) when it is overexpressed in
Drosophila, suggesting a possible link
between an iRhom and EGFR signaling
in mammals (Freeman, 2008). In a recent
issue of Cell, Zettl et al. (2011) show in
both Drosophila and mammalian cells
that iRhoms regulate growth factor
signaling (e.g., EGFR pathways) through
the ER quality control machinery that
function in endoplasmic reticulum-asso-ciated protein degradation (ERAD)
(Figure 1).
About one third of the eukaryotic ge-
nome encodes membrane and secretory
proteins, most of which undergo folding
and modification in the ER. Protein folding
is the most error-prone process in gene
expression. When ER homeostasis is dis-
rupted, or when cells are stimulated to
secrete large amounts of protein, unfolded
and misfolded proteins accumulate in the
ER and activate the unfolded protein
response (UPR). The UPR is a group of
adaptive signaling pathways that increase
the capacity for ER protein folding, at-
tenuate global mRNA translation, and
enhance protein degradation through
the transcriptional induction of the ERAD
machinery (Ron andWalter, 2007). Eukary-
otic cells have evolved a robust ER quality
control system that recognizes correctly
folded proteins for trafficking to the Golgi
compartment. In contrast, unfolded and
misfolded proteins are retained in the ERfor chaperone-assisted refolding. If mis-
folding persists, proteins are targeted to
the ERAD pathway, which requires retro-
translocation from theER to the cytoplasm,
where they are polyubiquitylated and
degraded by the proteasome (Hebert
et al., 2010).
In this study, Zettl et al. (2011) first
confirmed previous results by showing
that Drosophila, murine, and human
iRhoms are catalytically inert against a
variety of rhomboid substrates, including
Drosophila EGFR ligands and murine
EGF.Unlike the active rhomboidproteases
that reside in the Golgi and plasma
membrane, the iRhoms localize to the ER.
To reveal the function of iRhoms, Zettl
et al. (2011) then applied Drosophila
genetics. In Drosophila embryos, larvae,
and adults, iRhom RNA is enriched in
neuronal cells, suggesting that iRhoms
may act in the development and/or func-
tion of the nervous system. The authors
generated a Drosophila null mutant of
